Bridgewater Associates - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 246 filers reported holding HAEMONETICS CORP in Q3 2021. The put-call ratio across all filers is 1.26 and the average weighting 0.1%.

Quarter-by-quarter ownership
Bridgewater Associates ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$5,388,416
+14.7%
60,152
+9.0%
0.03%
+13.8%
Q2 2023$4,699,302
-7.9%
55,195
-10.4%
0.03%
-6.5%
Q1 2023$5,099,800
+8.9%
61,629
+3.5%
0.03%
+19.2%
Q4 2022$4,681,799
-21.9%
59,527
-26.5%
0.03%
-13.3%
Q3 2022$5,995,000
+13.5%
80,981
-0.1%
0.03%
+36.4%
Q2 2022$5,283,000
+13.7%
81,045
+10.3%
0.02%
+15.8%
Q1 2022$4,646,000
+56.5%
73,493
+31.3%
0.02%
+11.8%
Q4 2021$2,969,000
-11.8%
55,975
+17.4%
0.02%
-5.6%
Q3 2021$3,365,000
-2.7%
47,669
-8.2%
0.02%
-18.2%
Q2 2021$3,459,00051,9050.02%
Other shareholders
HAEMONETICS CORP shareholders Q3 2021
NameSharesValueWeighting ↓
Iron Triangle Partners LP 330,000$36,633,0004.66%
BEACONLIGHT CAPITAL, LLC 156,395$17,361,0002.80%
Bridge City Capital, LLC 48,011$5,330,0001.77%
Summit Creek Advisors LLC 121,362$13,472,0001.61%
Sivik Global Healthcare LLC 25,000$2,775,0001.01%
ANCHOR CAPITAL ADVISORS LLC 412,218$45,760,0000.97%
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income 69,655$7,732,0000.90%
Orbimed Advisors 852,000$94,581,0000.88%
LONDON CO OF VIRGINIA 1,057,738$117,420,0000.67%
WEXFORD CAPITAL LP 40,138$4,456,0000.66%
View complete list of HAEMONETICS CORP shareholders